234 related articles for article (PubMed ID: 16773719)
1. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin gene rearrangement in immunoproliferative small intestinal disease (IPSID).
Smith WJ; Price SK; Isaacson PG
J Clin Pathol; 1987 Nov; 40(11):1291-7. PubMed ID: 3121678
[TBL] [Abstract][Full Text] [Related]
3. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
Al-Saleem T; Al-Mondhiry H
Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
[TBL] [Abstract][Full Text] [Related]
4. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
[TBL] [Abstract][Full Text] [Related]
5. Nonsecretory alpha-chain disease with immunoproliferative small-intestinal disease.
Matuchansky C; Cogné M; Lemaire M; Babin P; Touhard G; Chamaret S; Preud'homme JL
N Engl J Med; 1989 Jun; 320(23):1534-9. PubMed ID: 2498659
[No Abstract] [Full Text] [Related]
6. [Alpha-heavy chain disease--Mediterranean lymphoma].
Kaufmann HP; Schmitt W; Seib HJ
Leber Magen Darm; 1994 Feb; 24(1):32-5. PubMed ID: 8145624
[TBL] [Abstract][Full Text] [Related]
7. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
Shih LY; Liaw SJ; Dunn P; Kuo TT
J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
[TBL] [Abstract][Full Text] [Related]
10. Immunoproliferative small intestinal disease (IPSID) in Thailand.
Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric measurement of proliferation-associated nuclear antigen P105 and DNA content in immuno-proliferative small intestinal disease (IPSID).
Demirer T; Uzunalimoglu O; Anderson T; Koethe SM; McFadden PW; Demirer S; Uzunalimoglu B; Kucuk O
J Surg Oncol; 1995 Jan; 58(1):25-30. PubMed ID: 7529850
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of an early stage IPSID using Syndecan 1.
Ramaswami PK; Joshi HV; Thomas R; Thomas R; Panackel C; Mathai SK
Trop Gastroenterol; 2014; 35(3):195-6. PubMed ID: 26012330
[No Abstract] [Full Text] [Related]
13. Immunoproliferative small intestinal disease (IPSID).
Pervez S; Mumtaz K; Ullah SS; Akhtar N; Ali N; Aaqil H
J Coll Physicians Surg Pak; 2011 Jan; 21(1):57-8. PubMed ID: 21276391
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
15. [Immunoproliferative small intestinal disease (IPSID): IPSID-like lymphomas, IPSID equivalents?, in 12 Spanish patients].
Sánchez-Fayos Calabuig P; Hernández Guío C; Porres Cubero JC; Olavarría López-Aróstegui E; Rivas Manga C; Outeiriño Hernanz J; Sánchez Fayos J
Sangre (Barc); 1995 Dec; 40(6):485-9. PubMed ID: 8850232
[TBL] [Abstract][Full Text] [Related]
16. The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
AlYamany R; Kharfan-Dabaja MA; Hamadani M; Alshaibani A; Aljurf M
Curr Oncol; 2022 May; 29(5):3759-3769. PubMed ID: 35621691
[TBL] [Abstract][Full Text] [Related]
17. Heavy Chain Disease of the Small Bowel.
Bianchi G; Sohani AR
Curr Gastroenterol Rep; 2018 Jan; 20(1):3. PubMed ID: 29372346
[TBL] [Abstract][Full Text] [Related]
18. Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease.
Price SK
Histopathology; 1990 Jul; 17(1):7-17. PubMed ID: 2227833
[TBL] [Abstract][Full Text] [Related]
19. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
Zahner J; Kirchner T; Ott G; Schneider W
Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
[TBL] [Abstract][Full Text] [Related]
20. [Immunoproliferative disease of the small intestine. A rare differential diagnosis of Crohn's disease].
Pohl C; Eidt S; Ziegenhagen D; Kruis W
Dtsch Med Wochenschr; 1991 Aug; 116(34):1265-9. PubMed ID: 1874129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
